HealthyWay Inc. (HKG:2587)
Hong Kong · Delayed Price · Currency is HKD 0.6600
-0.0550 (-7.69%)
Oct 2, 2026, 4:08 PM HKT
HealthyWay Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 577 | 3,831 | 11,480 | - | - | - | |
Market Cap Growth | -92.12% | -66.63% | - | - | - | - |
Enterprise Value | 342 | 3,645 | 11,412 | - | - | - |
Last Close Price | 0.66 | 4.37 | 13.08 | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 8.68 | 61.83 | - | - | - | - |
PS Ratio | 0.27 | 2.20 | 8.98 | - | - | - |
PB Ratio | 1.79 | 12.17 | 46.54 | - | - | - |
P/TBV Ratio | 2.30 | 16.02 | 78.81 | - | - | - |
P/FCF Ratio | 14.96 | 46.02 | 193.43 | - | - | - |
P/OCF Ratio | 14.87 | 45.92 | 190.27 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.16 | 2.10 | 8.93 | - | - | - |
EV/EBITDA Ratio | 3.79 | 32.52 | 236.51 | - | - | - |
EV/EBIT Ratio | 5.34 | 56.41 | 791.87 | - | - | - |
EV/FCF Ratio | 8.87 | 43.79 | 192.27 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.08 | 0.15 | 0.29 | -0.06 | -0.04 | -0.01 |
Debt / EBITDA Ratio | 0.30 | 0.39 | 1.38 | 3.68 | 5.37 | - |
Debt / FCF Ratio | 0.71 | 0.55 | 1.22 | 40.29 | 6.36 | 1.11 |
Net Debt / Equity Ratio | -0.76 | -0.83 | -0.85 | 0.05 | 0.01 | 0.03 |
Net Debt / EBITDA Ratio | -2.84 | -2.33 | -4.32 | -3.39 | -2.30 | 0.46 |
Net Debt / FCF Ratio | -6.35 | -3.14 | -3.52 | -31.47 | -2.22 | -2.28 |
Asset Turnover | 2.93 | 2.44 | 2.42 | 4.04 | 3.42 | - |
Inventory Turnover | 194.15 | 227.24 | 80.02 | 86.65 | 107.36 | - |
Quick Ratio | 1.37 | 1.36 | 1.19 | 0.15 | 0.08 | 0.07 |
Current Ratio | 1.44 | 1.42 | 1.34 | 0.16 | 0.10 | 0.09 |
Return on Equity (ROE) | 22.11% | 21.12% | - | - | - | - |
Return on Assets (ROA) | 5.65% | 5.67% | 1.71% | 1.49% | 2.84% | - |
Return on Invested Capital (ROIC) | 81.05% | 126.91% | - | - | - | - |
Return on Capital Employed (ROCE) | 19.70% | 20.10% | 5.70% | -0.40% | -0.50% | 5.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 11.56% | 1.62% | -2.49% | - | - | - |
FCF Yield | 6.68% | 2.17% | 0.52% | - | - | - |
Buyback Yield / Dilution | -10.05% | -22.66% | -2.25% | - | - | - |